the Board of Directors of AMAG approved awards to Mr. Sanchez of (i) an option to purchase 15,000 shares of common stock and (ii) 2,500 restricted stock units. The option will have an exercise price equal to the closing price of AMAG's …
AMAG Pharmaceuticals, Inc (Nasdaq: AMAG) today announced the pricing of $300 million aggregate principal amount of 3.25% Convertible Senior Notes due 2022 (the "notes") in ... will receive shares of AMAG common stock, cash or a …
(4-traders.com) NEW YORK, June 8, 2017 /PRNewswire/ -- On Wednesday, the New York headquartered NASDAQ …
Amag Pharmaceuticals (AMAG): AMAG stock is up 4.3% today ... Article printed from InvestorPlace Media, http://investorplace.com/2015/08/hottest-healthcare-stocks-now-lxrx-srpt-mack-amag-lxrx-srpt-mack/.
Still, news of Amag's biggest deal ever and Chief Executive William Heiden's assertion to hunt for growth through acquisitions failed to move shareholders. The stock was flat in morning trading. Cord Blood Registry (CBR), owned by …
Upon conversion, holders of the notes will receive shares of AMAG common stock, cash or a combination thereof, at …
“We met with the FDA to ask what they were seeing, and we provided [safety] data to them,” recalls Amag’s CEO, Brian Pereira, a trained nephrologist who invited Xconomy to breakfast ... By late that month, Amag’s stock had dropped …
The transaction was announced on September 29, 2014 and included upfront consideration of $600 million in cash and 3,209,971 shares of AMAG common stock, and additional contingent consideration of up to $350 million based on the …
... pay Endoceutics $50 million of total upfront consideration and issue Endoceutics 600,000 unregistered shares of …
On Wednesday, the New York headquartered NASDAQ Composite ended the day at 6,297.38, up 0.36%; the Dow …